Compound details
Assamicain A
| Compound ID | CDAMM01096 |
|---|---|
| Common name | Assamicain A | IUPAC name | [5,7-dihydroxy-8-[2-(3,4,5-trihydroxybenzoyl)oxy-3-(2,4,6-trihydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)propyl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate |
| Molecular formula | C44H36O22 |
| Retention time | 0.5 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 917.179 | Theoretical mz | 917.177 |
| Error | 1.88 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.9161 |
| Inchi key | SKYSKYXPHIEIOH-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C(OC1CC2=C(O)C=C(O)C(=C2OC1C3=CC(O)=C(O)C(O)=C3)C(C4=CC(O)=C(O)C(O)=C4)C(OC(=O)C5=CC(O)=C(O)C(O)=C5)CC=6C(O)=CC(O)=CC6O)C7=CC(O)=C(O)C(O)=C7 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P05067 | APP | Beta amyloid A4 protein | T87024 | SwissTargetPrediction |
| Q14534 | SQLE | Squalene monooxygenase (by homology) | T93344 | SwissTargetPrediction |
| P05121 | SERPINE1 | Plasminogen activator inhibitor-1 | T15556 | SEA |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SEA |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P50281 | MMP14 | Matrix metalloproteinase 14 | T65019 | SwissTargetPrediction |
| P52209 | PGD | 6-phosphogluconate dehydrogenase | T76497 | SwissTargetPrediction and SEA |
| P22083 | FUT4 | Fucosyltransferase 4 | T51146 | SwissTargetPrediction |
| P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | T64205 | SwissTargetPrediction |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SwissTargetPrediction |
| Q99417 | MYCBP | MYCBP messenger RNA | T37298 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T93344 | DI0118 | Dermatophytosis | [ICD-11: 1F28] | Q14534 | SQLE |
| T93344 | DI0385 | Skin fungal infection disorder | [ICD-11: EA60] | Q14534 | SQLE |
| T15556 | DI0037 | Asthma | [ICD-11: CA23] | P05121 | SERPINE1 |
| T15556 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P05121 | SERPINE1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T65019 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P50281 | MMP14 |
| T76497 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P52209 | PGD |
| T51146 | DI0441 | Appendicitis | [ICD-11: DB10] | P22083 | FUT4 |
| T64205 | DI0383 | Skin and skin-structure infection | [ICD-11: 1F28-1G0Z] | P42224 | STAT1 |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T37298 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q99417 | MYCBP |